文献速递乳腺乳腺X线

数字乳腺X线摄影与数字乳腺X线摄影联合断层合成在乳腺癌筛查中的比较:奥斯陆断层合成筛查试验

Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial.
PubMed 文献 · Radiology · 2019-02-19

这项前瞻性研究纳入24 301名女性、281例癌症,比较数字乳腺X线摄影(DM)与DM联合数字乳腺断层合成(DBT)的筛查准确性,并评估合成乳腺X线摄影(SM)联合DBT及计算机辅助检测(CAD)的作用。DM+DBT较DM敏感度提高、假阳性率降低;SM+DBT与DM+DBT敏感度和特异度相似;加用CAD的差异小且无统计学意义。

要点

  • DM+DBT较DM敏感度提高(70.5% vs 54.1%),假阳性率降低(5.0% vs 5.8%)。
  • SM+DBT与DM+DBT敏感度(69.0% vs 70.5%)和特异度相似,差异无统计学意义。
  • 加用CAD对敏感度和特异度的改善小且无统计学意义(P > .2)。

核心结论

  • 在数字乳腺X线摄影基础上加用数字乳腺断层合成可显著提高敏感度并降低假阳性率。
  • 合成乳腺X线摄影联合数字乳腺断层合成的敏感度和特异度与数字乳腺X线摄影联合数字乳腺断层合成相似。

研究设计与样本

  • 前瞻性研究,2010年11月至2012年12月纳入24 301名女性(平均年龄59.1岁±5.7),共281例癌症,其中51例为间期癌。
  • 每例检查以四种阅片模式独立判读:DM、DM+CAD、DM+DBT、SM+DBT,并以双阅片比较DM与DM+DBT。
  • 基于仲裁前(初始判读)评分评估各阅片模式的读者校正性能特征,统计分析采用10 000次随机重抽样的聚类自助法。

诊断标准与关键数值

  • DM敏感度54.1%(152/281),DM+DBT敏感度70.5%(198/281),读者校正差值12.6%(95%CI:5.2%,19.7%;P = .001)。
  • DM特异度94.2%(假阳性率5.8%;1388/24 020),DM+DBT特异度95.0%(假阳性率5.0%;1209/24 020),假阳性率读者校正差值-1.2%(95%CI:-1.7%,-0.7%;P < .001)。
  • SM+DBT敏感度69.0%(194/281),DM+DBT敏感度70.5%(198/281),读者校正差值1.0%(95%CI:-6.2%,8.5%;P = .77)。
  • SM+DBT特异度95.4%(假阳性率4.6%;1111/24 020),DM+DBT特异度95.0%(假阳性率5.0%;1209/24 020),假阳性率读者校正95%CI分别为4.7%、5.4%和5.0%、5.7%,差值-0.3%(95%CI:-0.8%,0.2%;P = .23)。
  • 加用CAD后敏感度和特异度的差异小且无统计学意义(P > .2)。

临床应用与阅片要点

  • 在人群乳腺筛查中,DM+DBT较DM可提高敏感度并降低假阳性率。
  • 合成乳腺X线摄影联合DBT与DM联合DBT的敏感度和特异度相似,差异无统计学意义。
  • 加用CAD对敏感度和特异度的改善小且无统计学意义(P > .2)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Digital breast tomosynthesis (DBT) is replacing digital mammography (DM) in the clinical workflow. Currently, there are limited prospective studies comparing the diagnostic accuracy of both examinations and the role of synthetic mammography (SM) and computer-aided detection (CAD). Purpose To compare the accuracy of DM versus DM + DBT in population-based breast cancer screening. Materials and Methods This prospective study, performed from November 2010 to December 2012, included 24 301 women (mean age, 59.1 years ± 5.7 [standard deviation]) with 281 cancers, of which 51 were interval cancers. Each examination was independently interpreted with four reading modes: DM, DM + CAD, DM + DBT, and SM + DBT. Sensitivity and specificity were compared for DM versus DM + DBT, DM versus DM + CAD, DM + DBT versus SM + DBT, and DM versus DM + DBT at double reading. Reader-adjusted performance characteristics of reading modes were evaluated on the basis of pre-arbitration (initial interpretation) scores. Statistical analysis was based on cluster bootstrap analysis using 10 000 random resamples. Results Sensitivity was 54.1% (152 of 281) for DM and 70.5% (198 of 281) for DM + DBT. Reader-adjusted difference was 12.6% (95% confidence interval [CI]: 5.2%, 19.7%; P = .001). Specificity was 94.2% (false-positive fraction [FPF], 5.8%; 1388 of 24 020) for DM and 95.0% (FPF, 5.0%; 1209/24 020) for DM + DBT, with a reader-adjusted difference in FPF of -1.2% (95% CI: -1.7%, -0.7%; P < .001). Sensitivity was 69.0% (194 of 281) for SM + DBT and 70.5% (198 of 281) for DM + DBT, with a reader-adjusted difference of 1.0% (95% CI: -6.2%, 8.5%; P = .77). Specificity was 95.4% (FPF, 4.6%; 1111 of 24 020) for SM + DBT and 95.0% (FPF, 5.0%;1209 of 24 020) for DM + DBT, with reader-adjusted 95% CIs for FPF of 4.7%, 5.4% and 5.0%, 5.7%, respectively, and a difference of -0.3% (95% CI: -0.8%, 0.2%; P = .23). Differences in sensitivity and specificity with the addition of CAD were small and not significant (P > .2). Conclusion Addition of digital breast tomosynthesis to digital mammography resulted in significant gains in sensitivity and specificity. Synthetic mammography in combination with digital breast tomosynthesis had similar sensitivity and specificity to digital mammography in combination with digital breast tomosynthesis. © RSNA, 2019 See also the editorial by Lång in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Skaane P, Bandos AI, Niklason LT, et al. Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening Trial. Radiology. 2019. PMID: 30777808. doi:10.1148/radiol.2019182394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。